GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 28848
Submission : 2014-11-20
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 28848
Submission : 2014-11-20
Status : Active
Type : IV
FINISHED DOSAGE FORMULATIONS
Drug : PLAVIX
Dosage Form : TABLET; ORAL
Application Number : 20839
Country : US
Patented : No
Drug : FLOMAX
Dosage Form : CAPSULE; ORAL
Application Number : 20579
Country : US
Patented : No
Drug : OXYTROL FOR WOMEN
Dosage Form : FILM, EXTENDED RELEASE; TRANSDERMAL
Application Number : 202211
Country : US
Patented : No
Drug : DEPAKOTE ER
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 21168
Country : US
Patented : No
Drug : OXYTROL
Dosage Form : FILM, EXTENDED RELEASE; TRANSDERMAL
Application Number : 21351
Country : US
Patented : No
ESTROGENS, CONJUGATED SYNTHETIC B
Drug : ENJUVIA
Dosage Form : TABLET; ORAL
Application Number : 21443
Country : US
Patented : No
Drug : NEXICLON XR
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 22500
Country : US
Patented : Yes
Drug : RAMELTEON
Dosage Form : TABLET; ORAL
Application Number : 91693
Country : US
Patented : No
Drug : SUMATRIPTAN SUCCINATE
Dosage Form : TABLET; ORAL
Application Number : 76847
Country : US
Patented : No
Drug : TINDAMAX
Dosage Form : TABLET; ORAL
Application Number : 21618
Country : US
Patented : No
EXCIPIENTS BY APPLICATIONS
MARKET PLACE
REF. STANDARDS & IMPURITIES